Press Releases                                              

Apple Inc. (Nasdaq: AAPL) Is Still Struggling
Shares of Apple Inc. (Nasdaq: AAPL) are testing key support levels.



Chart Courtesy of StockCharts.com


Apple has been the market's darling for several years. Its iPod, iPhones, and now its iPad line of personal computers, smart phones, and music players have clearly captured the imagination of the public. And its billions in sales have been impressive.

But the stock has had its troubles lately, having topped out in June, near 280, and having been stuck in a trading range with the 230-250 area as support for several months.

Apple's problems with its newest phone's antenna didn't help. But neither is the competition from Motorola's Android line, and a host of other smart phones, including the now considered old-fashioned BlackBerry.

Is this the end of the line for Apple? Not likely. But rising competition won't make things easier either, especially if the company makes another blunder, such as the antenna gaffe of the last few weeks.

From a longer and broader term standpoint, Apple's performance is also important for the Nasdaq Composite and the Nasdaq 100 indexes, where it has a fairly heavy weight.

For now, it looks as if Apple is consolidating. But a move below that 230-250 support band would be a big negative.

Follow Dr. Duarte on Twitter

Make money if any market rises or falls, with a copy of "Market Timing For Dummies."

“Futures And Options For Dummies,” Dr. Duarte’s latest book is now available. The markets are responding to news and geopolitical developments like never before. In this environment, individual investors need to expand their investment horizons. "Futures And Options For Dummies " (John Wiley & Sons) has an excellent section on oil futures as well as the currency markets, while covering and expanding on the successful strategies in Doctor Duarte's other books. Order your copy today.

Doctor Joe Duarte's Market I.Q., offers subscribers a unique blend of intelligence, market commentary and trading strategy. Duarte's daily articles, and news summaries offer recommendations and analysis for ETFs, and individual stocks in the technology, health and biotechnology, and energy sectors. Doctor Duarte is a writer, and an emerging futurist, with a diverse background, and a growing audience. His combined expertise in health care, energy, and the effects of politics and global intelligence on the financial markets offer a unique blend of insight and information to thousands of active investors and political and intelligence aficionados around the world on a daily basis.

He is the author of four books: "Futures And Options For Dummies," "Successful Energy Sector Investing," "Successful Biotech Investing" and co-author of "After-Hours Trading Made Easy."

In early 2001 Dr. Duarte in "Successful Energy Sector Investing," correctly predicted that Venezuela's political problems could lead to an energy crisis in the United States.

In 2003, also Dr. Duarte was among the first to widely publicize the long-term friendship between French President Jacques Chirac and Saddam Hussein.

He has also appeared as a weekly guest on Market Mavens Radio, has logged appearances on KNX radio in Los Angeles, Financial Sense.com radio, and Wall Street Radio.

One of CNBC's original Market Mavens, Dr. Duarte has been writing about the financial markets since 1990.

His articles and commentary have been featured on CBS Marketwatch, Barron's, Smart Money, Medical Economics, and in Technical Analysis of Stocks and Commodities magazines.

In 2003, Doctor Duarte received second place, in the professional section, of the Medical Economics Investment Challenge with a 12-month return of 42%.




Joe-Duarte.com is independently operated and solely funded by subscriber fees. This web site and the content provided is meant for educational purposes only and is not a solicitation to buy or sell any securities or investments. All sources of information are believed to be accurate, or as otherwise stated. Dr. Duarte and the publishers, partners, and staff of Joe-Duarte.com have no financial interest in any of the sources used. For independent investment advice consult your financial advisor. The analysis and conclusions reached on Joe-Duarte.com are the sole property of Dr. Joe Duarte.